DEADLINE: ANDHealth+ Program
28 September @ 4:00 pm - 5:00 pm AWST
ANDHealth+ is a commercialisation acceleration program for innovative digital and connected health technologies with demonstrable commercial and clinical impact potential.
The two-stage program supports proof-of-concept stage, evidence-based digital and connected health SMEs through:
- Up to $5 million non-dilutive project funding, tranched according to agreed milestones
- Significant in-kind support, specialised expertise and hands-on resources
- A global network of industry advisors, investors, clinicians, executives and corporate partners
- Cohort and alumni-only events and opportunities
- With no equity requirements or IP transfer.
Selected participants will work with a dedicated ANDHealth support team and an Industry Advisory Panel to address and overcome key challenges along the commercialisation pathway.
Each intake, up to five companies are selected via a proven and competitive assessment process, driven by a multi-sectoral, multi-disciplinary group of industry leaders with experience in evaluating and selecting high-potential SMEs.
ANDHealth is supported to deliver the ANDHealth+ program by the Australian Government through the Medical Research Future Fund (MRFF) Medical Research Commercialisation Initiative.